Rossi Franca, Del Matto Ilaria, Saletti Maria Antonietta, Ricchiuti Luciano, Tucci Patrizia, Marino Lucio
Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise, Sezione di Campobasso, 86100 Campobasso, Italy.
Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise, Sezione di Lanciano, 66034 Lanciano, Italy.
Antibiotics (Basel). 2023 Feb 21;12(3):430. doi: 10.3390/antibiotics12030430.
This study aimed to investigate the recent trends of antibiotic resistance (AR) prevalence in isolated from the milk of animals with clinical mastitis in areas of the Abruzzo and Molise regions in Central Italy. Fifty-four isolates were obtained from routine testing for clinical mastitis agents carried out in the author institution in the years 2021 and 2022 and were analyzed for phenotypic resistance to eight antibiotics recommended for testing by European norms and belonging to the antibiotic classes used for mastitis treatment in milk-producing animals. Moreover, the presence of 14 transferable genetic determinants encoding resistance to the same antibiotics was analyzed using qPCR tests developed in this study. Phenotypic resistance to non-β-lactams was infrequent, with only one 2022 isolate resistant to clindamycin. However, resistance to the β-lactam cefoxitin at concentrations just above the threshold of 4 µg/mL was observed in 59.2% of isolates in both years, making these isolates classifiable as methicillin-resistant. The AR genotypes detected were the Z gene (50% of 2021 isolates and 44.4% of 2022 isolates), A3-Z- C/T (one 2021 isolate), A3-6-Z-C/T (one 2021 isolate), ZB (one 2022 isolate) and A- (one 2022 isolate). An inquiry into the veterinarians who provided the samples, regarding the antimicrobials prescribed for mastitis treatment and criteria of usage, indicated a possible causal relation with the AR test results. The occurrence of AR genotypes did not increase in time, most probably reflecting how mastitis was treated and prevented in farms. However, the frequently observed cefoxitin resistance needs to be explained genotypically, further monitored and limited by modifying antibiotic usage practices. The identification of a A-positive isolate in 2022 suggests further investigation if this genotype is emerging locally.
本研究旨在调查意大利中部阿布鲁佐和莫利塞地区患有临床乳腺炎的动物乳汁中分离出的细菌的抗生素耐药性(AR)流行趋势。从作者所在机构在2021年和2022年对临床乳腺炎病原体进行的常规检测中获得了54株分离菌,并对其进行了针对欧洲规范推荐检测的8种抗生素的表型耐药性分析,这些抗生素属于用于产奶动物乳腺炎治疗的抗生素类别。此外,使用本研究开发的qPCR检测分析了14种编码对相同抗生素耐药性的可转移遗传决定因素的存在情况。对非β-内酰胺类抗生素的表型耐药性很少见,2022年只有一株分离菌对克林霉素耐药。然而,在这两年中,59.2%的分离菌对浓度略高于4μg/mL阈值的β-内酰胺类头孢西丁耐药,这些分离菌可归类为耐甲氧西林菌。检测到的AR基因型有Z基因(2021年分离菌的50%和2022年分离菌的44.4%)、A3-Z-C/T(一株2021年分离菌)、A3-6-Z-C/T(一株2021年分离菌)、ZB(一株2022年分离菌)和A-(一株2022年分离菌)。对提供样本的兽医就乳腺炎治疗所用抗菌药物及使用标准进行的询问表明,这可能与AR检测结果存在因果关系。AR基因型的出现并没有随时间增加,很可能反映了农场中乳腺炎的治疗和预防方式。然而,经常观察到的头孢西丁耐药性需要从基因型上进行解释,进一步监测并通过改变抗生素使用方法加以限制。2022年鉴定出一株A阳性分离菌,表明如果这种基因型在当地出现,需要进一步调查。